People Background Check
Find People:

Michael E Jeffers, Age 66162 N Walnut St, Ridgewood, NJ 07450

Get Report
Known as:
Michael Jeffers Ooi Michael E Feffers Mike Jeffers Jeffers Michael
Related to:
Carleen Jeffers

Michael Jeffers Phones & Addresses

162 N Walnut St, Ridgewood, NJ 07450 (201) 444-6299

Branford, CT

140 Mill St, East Haven, CT 06512

7718 Havenside Ter, Derwood, MD 20855

Rockville, MD

Work

Company: BB&T Mortgage Address: 7220 Wisconsin Ave, Bethesda, MD 20814 Phones: (301) 961-9627 (Office)

Education

School / High School: University of Washington, Nyu

Ranks

Licence: New York - Currently registered Date: 1970

Mentions for Michael E Jeffers

Career records & work history

Real Estate Brokers

Michael Jeffers Photo 1

Asst Vp

Specialties:
Purchase Loan, Refinancing, Home Equity
Work:
BB&T Mortgage
7220 Wisconsin Ave, Bethesda, MD 20814
(301) 961-9627 (Office)

Lawyers & Attorneys

Michael Jeffers Photo 2

Michael Bogue Jeffers - Lawyer

Licenses:
New York - Currently registered 1970
Education:
University of Washington, Nyu
Michael Jeffers Photo 3

Michael Jeffers - Lawyer

Office:
Jeffers, Kevin
ISLN:
906184804
Admitted:
1988

License Records

Michael Lea Jeffers

Licenses:
License #: 384718 - Expired
Category: Contractor
Issued Date: Mar 9, 2015

Publications & IP owners

Us Patents

Nucleotide Sequences And Amino Acid Sequences Of Secreted Proteins Involved In Angiogenesis

US Patent:
6537554, Mar 25, 2003
Filed:
Sep 11, 2000
Appl. No.:
09/658644
Inventors:
Richard A. Shimkets - West Haven CT
Michael Jeffers - Branford CT
Assignee:
Curagen Corporation - New Haven CT
International Classification:
A61K 3900
US Classification:
4241981, 4241841, 435 4, 436 64
Abstract:
Novel angiogenesis/anti-angiogenesis secreted proteins and the nucleic acid sequences which encode them are disclosed by the present invention.

Methods Of Prevention And Treatment Of Inflammatory Bowel Disease

US Patent:
6982250, Jan 3, 2006
Filed:
Nov 16, 2001
Appl. No.:
10/011364
Inventors:
Henry Lichenstein - Guilford CT, US
Michael Jeffers - Branford CT, US
Assignee:
CuraGen Corporation - New Haven CT
International Classification:
A61K 38/00
C07K 17/00
US Classification:
514 12, 514 2, 530350
Abstract:
The present invention is based upon methods of treating inflammatory conditions in the intestinal tract of mammals using growth factor related polypeptides. The invention includes methods of reducing the morality rate or delaying mortality in a subject suffering from an inflammatory pathology. Methods of using fibroblast growth factor-CX (FGF-CX) polynucleotide sequences and the FGF-CX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, are claimed in the invention. Similarly, methods of using FCTRX polynucleotide sequences and the FCTRX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, alone or in combination, are also claimed in the invention. FCTRX collectively refers to any of six variant FCTRX sequences, variously designated FCTR1, FCTR2, FCTR3, FCTR4, FCTR5 and FCTR6.

Fibroblast Growth Factor And Nucleic Acids Encoding Same

US Patent:
7056885, Jun 6, 2006
Filed:
Jul 3, 2000
Appl. No.:
09/609543
Inventors:
Michael Jeffers - Branford CT, US
Richard A. Shimkets - West Haven CT, US
Sudhirdas K. Prayaga - East Haven CT, US
Ferenc L. Boldog - North Haven CT, US
Meijia Yang - East Lyme CT, US
Catherine Burgess - Wethersfield CT, US
Elma Fernandes - Branford CT, US
John L. Herrmann - Gilford CT, US
William J. LaRochelle - Madison CT, US
Henri Lichenstein - Madison CT, US
Assignee:
CuraGen Corporation - Branford CT
International Classification:
A61K 38/18
C07K 14/50
US Classification:
514 12, 530350, 530399, 530402
Abstract:
The present invention provides FGF-CX polypeptides and polynucleotides, and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods of use for the FGF-CX polypeptide, polynucleotide and antibody.

Treatment Of Inflammatory Bowel Disease Using Fibroblast Growth Factor Cx Polypeptides

US Patent:
7189693, Mar 13, 2007
Filed:
Dec 16, 2002
Appl. No.:
10/321962
Inventors:
Michael E. Jeffers - Branford CT, US
William J. LaRochelle - Madison CT, US
Henri S. Lichenstein - Guilford CT, US
Assignee:
CuraGen Corporation - Branford CT
International Classification:
A61K 38/00
C07K 14/00
US Classification:
514 12, 514 2, 530350
Abstract:
The present invention is based upon methods of treating inflammatory conditions in the intestinal tract of mammals using growth factor related polypeptides. The invention includes methods of reducing the mortality rate or delaying mortality in a subject suffering from an inflammatory pathology. Methods of using fibroblast growth factor-CX (FGF-CX) polynucleotides sequences and the FGF-CX polypeptides encoded by such nucleic acid sequence, or variants, fragments and homologs thereof, are claimed in the invention. Similarly, methods of using FCTRX polynucleotide sequences and the FCTRX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, alone or in combination, are also claimed in the invention. FCTRX collectively refers to any of six variant FCTRX sequences, variously designated FCTR1, FCTR2, FCTR3, FCTR4, FCTR5 and FCTR6.

Polypeptides Of Fgf-Cx

US Patent:
7253266, Aug 7, 2007
Filed:
Jun 17, 2002
Appl. No.:
10/174394
Inventors:
Richard A. Shimkets - West Haven CT, US
Michael Jeffers - Branford CT, US
Sudhirdas K. Prayaga - East Haven CT, US
Ferenc L. Boldog - North Haven CT, US
Meijia Yang - East Lyme CT, US
Catherine Burgess - Wethersfield CT, US
Elma Fernandes - Branford CT, US
John L. Herrmann - Gilford CT, US
William J. LaRochelle - Madison CT, US
Henri Lichenstein - Madison CT, US
Linda Gorman - Branford CT, US
Mei Zhong - Branford CT, US
Muralidhara Padigaru - Branford CT, US
Carol E. A. Pena - New Haven CT, US
Denise M. Lepley - Branford CT, US
Daniel K. Rieger - Branford CT, US
William Grosse - Branford CT, US
Assignee:
CuraGen Corporation - Branford CT
International Classification:
C07K 14/50
A61K 38/18
A61K 38/00
G01N 33/53
US Classification:
530399, 530350, 514 12, 435975
Abstract:
The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as other uses.

Antibodies Against T Cell Immunoglobulin Domain And Mucin Domain 1 (Tim-1) Antigen And Uses Thereof

US Patent:
8067544, Nov 29, 2011
Filed:
Mar 19, 2004
Appl. No.:
10/805177
Inventors:
Gregory M. Landes - The Woodlands TX, US
Francine Chen - San Francisco CA, US
Binyam Bezabeh - Oakland CA, US
Ian Foltz - Burnaby, CA
Kam Fai Tse - Clinton CT, US
Michael Jeffers - Branford CT, US
Mehdi Mesri - Branford CT, US
Gary Starling - Clinton CT, US
Peter Mezes - Old Lyme CT, US
Nikolia Khramtsov - Branford CT, US
Assignee:
Curagen Corporation - New Haven CT
International Classification:
C07K 16/00
US Classification:
5303871, 4241301
Abstract:
The invention described herein is related to antibodies directed to the antigen TIM-1 and uses of such antibodies. In particular, there are provided fully human monoclonal antibodies directed to the antigen TIM-1. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.

Novel Fibroblast Growth Factor And Nucleic Acids Encoding Same

US Patent:
2002005, May 16, 2002
Filed:
Mar 26, 2001
Appl. No.:
09/817814
Inventors:
Michael Jeffers - Branford CT, US
Richard Shimkets - West Haven CT, US
Sudhirdas Prayaga - O'Fallon MO, US
Ferenc Boldog - North Haven CT, US
Meijia Yang - East Lyme CT, US
Catherine Burgess - Wethersfield CT, US
Elma Fernandes - Branford CT, US
John Herrmann - Gilford CT, US
William LaRochelle - Madison CT, US
Henri Lichenstein - Madison CT, US
International Classification:
A61K039/395
C07H021/04
C12N005/06
C07K014/50
US Classification:
424/145100, 435/325000, 435/320100, 536/023500, 530/399000
Abstract:
The present invention provides FGF-CX, a novel isolated polypeptide, as well as a polynucleotide encoding FGF-CX and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the FGF-CX polypeptide, polynucleotide and antibody are used in detection and treatment of a broad range of pathological states, as well as other uses.

Growth Factor Polypeptides And Nucleic Acids Encoding Same

US Patent:
2002009, Jul 18, 2002
Filed:
Feb 2, 2001
Appl. No.:
09/775482
Inventors:
Richard Shimkets - West Haven CT, US
Henri Lichenstein - Guilford CT, US
John Herrmann - Guilford CT, US
Ferenc Boldog - North Haven CT, US
Stacey Minskoff - Stamford CT, US
Michael Jeffers - Branford CT, US
David Andrews - Branford CT, US
William Rochelle - Madison CT, US
International Classification:
G01N033/567
US Classification:
435/007210
Abstract:
Disclosed are novel PDGFD nucleic acids encoding proteins and polypeptides related to bone morphogenetic protein-1 (BMF1), to vascular endothelial growth factor E (VEGF-E) and to platelet derived growth factor (PDGF). Also disclosed are vectors, host cells, antibodies, and recombinant methods for producing these nucleic acids and polypeptides. Methods of use include detecting and staging of cancers.

Isbn (Books And Publications)

Pathology: Pretest Self-Assessment And Review

Author:
Michael D. Jeffers
ISBN #:
0070519994

Pathology: Pretest Self-Assessment And Review

Author:
Michael D. Jeffers
ISBN #:
0070519757

Possible Relatives

David J Jeffers  Dawn L Jeffers  Dean L Jeffers  Denise L Jeffers  Danny L Jeffers  Diana M Jeffers  Don Jeffers  Michael A Last  Michael D Stanaland  Michael Stanberry 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.